metaBIX Biotech has achieved a significant milestone in the protection of its intellectual property by obtaining a patent in the United States for its CAPTUS device, which captures various airborne pathogens potentially harmful to animal production, food industry and human health.

Laura Macció, CEO of the startup, stated, “This is a milestone in protecting the knowledge we have generated as a company. We hope to soon obtain patents for our predictive model, which alerts us to the number of airborne pathogens capable of affecting animals or crops, and for a third innovation related to mathematical aspects and biotechnological data to predict or estimate the number of animals protected by an attenuated vaccine by measuring the vaccine present in the air.”

While the patent secures the intellectual property of CAPTUS in the United States, the application has also been filed through the Patent Cooperation Treaty (PCT) for protection in over 150 member countries.

“Obtaining this first patent enables us to initiate a pilot project in the second half of the year in the United States, focused on monitoring salmonella in poultry, with the aim of conducting a Soft-Landing in 2025,” Macció concluded.